MPOX
JOIN

Vaccines and Related Biological Products Advisory Committee Meeting Report April 6th

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on April 6, 2022 to discuss considerations for COVID-19 vaccine booster doses and process
for COVID-10 vaccine strain selection to address current and emerging variants.

See Below to download the VRBPAC Meeting Report from April 6th

More SAFETY TEMPLATES

Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessment

August 27, 2024

Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses

October 26, 2023

Live-attenuated viral vaccines: standardized template for collection of key information for benefit-risk assessment

October 13, 2023

Viral vector vaccines: standardized template for collection of key information for benefit-risk assessment

October 13, 2023

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment

October 13, 2023

Modified Vaccinia Ankara (MVA) vaccine platform: standardized template for collection of key information for risk/benefit assessment

October 4, 2023
View All

M
o
r
e
P
o
s
t
s

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

Linkedin

© Brighton Collaboration  2023. All rights reserved.